Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LifeStance Health Gr Q2 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate, Sales $312.331M Beat $307.565M Estimate

Author: Benzinga Newsdesk | August 08, 2024 06:04am
LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 53.85 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $312.331 million which beat the analyst consensus estimate of $307.565 million by 1.55 percent. This is a 20.32 percent increase over sales of $259.578 million the same period last year.

Posted In: LFST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist